TrialEuropean urology2018

Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial.

Shankar Siva et al.PubMed ↗Publisher ↗

No numbers read from the abstract.